5TEWLVES C, BUTTS C, CASSIDY J,et al.XELOX(capecitabine plus oxaliplatin), a safe and active first-line regimen for elderly patients with metastatic colorectal cancer(MCRC):Post-hoc analysis of a large phase Ⅱ study[J].Journal of Clinical Oncology,2004,22(14S):3555. 被引量：1
6CASSIDY J, TABERNERO J, TWELVES C,et al.XELOX(capecitabine plus oxaliplatin):active first-line therapy for patients with metastatic colorectal cancer[J].Journal of Clinical Oncology,2004,22(11):2084-2091. 被引量：1
二级参考文献3
1Cvitkovic E. Ongoing and unsaid on oxaliplatin: the hope[J].Br J cancer, 1998,77(suple ,4) :8-11. 被引量：1
2Ishikawa T,Sekinguchi F. Fukase Y. et al. Positive correlation between the efficacy capecitabine and doxofluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts[J].Cancer Res1998,58(4):685 -690. 被引量：1
